Experimental analysis shows glycoprotein biosynthesis inhibition in Helicobacter pylori, suggesting blocked pathways may offer treatment options.
A masked bis(pivaloyloxymethyl) phosphonate analogue of α- d -glucose 1-phosphate demonstrates significant glycoprotein biosynthesis inhibition in Helicobacter pylori using metabolic oligosaccharide engineering.
No takes yet. Share an insight, caveat, or question.
Soleimani et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: